Aerie Pharma (AERI) Tops Q4 EPS by 176c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Aerie Pharma (AERI) PT Lowered to $14 at Needham & Company
February 25, 2022 8:12 AM ESTNeedham & Company analyst Serge Belanger lowered the price target on Aerie Pharma (NASDAQ: AERI) to $14.00 (from $22.00) while maintaining a Buy rating.
The analyst commented, "AERI's 4Q21 earnings was an opportunity for new mgmt to introduce its approach to drive shareholder value. The... More
